
01 Sep 2020
LIBERUM: Oxford Biomedica - Astra deal quantifies COVID opportunity
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Oxford Biomedica - Astra deal quantifies COVID opportunity
Oxford BioMedica plc (OXB:LON) | 625 62.5 1.6% | Mkt Cap: 751.3m
- Published:
01 Sep 2020 -
Author:
Graham Doyle | Alistair Campbell | Fowey Harvey -
Pages:
7 -